iBio announces licensing agreement with AstralBio for a novel antibody targeting Activin E, potentially aiding weight loss and cardiometabolic health. Bio, Inc. has announced a licensing agreement ...
A new lipid nanoparticle platform delivers full-length antibodies inside cells, unlocking intracellular targets in cancer, ...
Antibodies, also known as immunoglobulins, are specialized proteins produced by the immune system to identify and neutralize foreign invaders, such as viruses, bacteria, and other pathogens. They are ...
An international research group directed by UMC Utrecht has developed and characterized two first-in-class antibodies that specifically block the high-affinity IgG receptor FcγRI. Their findings open ...
A novel class of antibodies that binds to a previously untargeted portion of the malaria parasite could lead to new prevention methods, according to a study by researchers at the National Institutes ...
Novel anti-malaria antibodies have been identified, potentially contributing to the next generation of malaria prevention. Researchers at the National Institutes of Health (MD, USA) have identified a ...
Antibodies that bind to a previously untargeted portion of the malaria parasite could lead to new monoclonal antibody treatments and vaccines for malaria. A novel class of antibodies that binds to a ...
July 15, 2026) - Frost & Sullivan has officially released the "Global Antibody Drug Industry Development Blue Book 2026". The Blue Book provides a systematic overview of the current landscape and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results